Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppression.
Journal: The Journal of clinical investigation
Published: July 07, 2026
QuTILs: Open-Source Image-Based Infiltrating Immune Cell Detection for Research Application.
Journal: Research square
Published: May 25, 2026
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 24, 2026
Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.
Journal: Journal for immunotherapy of cancer
Published: April 20, 2026
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 16, 2026
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 10, 2026
ASO Visual Abstract: The Association of Clinical Stage at Presentation with Overall Survival in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
Journal: Annals of surgical oncology
Published: September 30, 2025
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 26, 2025
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 26, 2025
ASO Author Reflections: Survival of Patients with HER2-Positive Breast Cancer After Neoadjuvant Chemotherapy Based on Presenting Clinical Stage and Response to Neoadjuvant Chemotherapy.
Journal: Annals of surgical oncology
Published: August 05, 2025
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial.
Journal: Breast cancer research : BCR
Published: April 24, 2025
The Association of Clinical Stage at Presentation with Overall Survival of Patients who have HER2-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
Journal: Annals of surgical oncology
Published: March 31, 2025
Last Updated: 09/26/2026